The Efficiency of Surgery and Radiotherapy After SHR-1316 (Adebrelimab) and Platinum-containing Doublet Induction Therapy for Limited-stage Small Cell Lung Cancer

NCT05496166 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

348

Enrollment

OTHER

Sponsor class

Conditions

Limited Stage Small Cell Lung Cancer

Interventions

COMBINATION_PRODUCT: chemotherapy and SHR-1316(Adebrelimab) comnined with surgery or radiotherapy

Sponsor

Shanghai Pulmonary Hospital, Shanghai, China

Collaborators

[object Object]